#BunnettLab
Targeting intracellular GPCR and RTK signalosomes offers a breakthrough approach for more effective and long-lasting chronic pain relief #GPCR #RTK #ChronicPain #Signalosomes #Bunnettlab
www.cell.com
March 12, 2025 at 9:00 PM
@tedpricethepainguy.bsky.social New insights on NGF signaling and pain relief! Could targeting NRP1&GIPC1 be the key to next-gen pain therapeutics? #NGF #PainResearch #Bunnettlab www.jci.org/articles/vie...
JCI - Reinvigorating drug development around NGF signaling for pain
www.jci.org
February 20, 2025 at 3:22 PM
Press release for 2 exciting papers from Bunnett and Jensen Lab researchers! #JensenLab #BunnettLab www.nyu.edu/about/news-p...
Microbiome and Nanoparticle Discoveries Hold Promise for Treating Gut Pain
Newly identified enzyme and targeted nanomedicines bring researchers closer to more effectively treating pain from digestive disorders
www.nyu.edu
October 17, 2025 at 4:36 PM